NO20025909L - Kombinasjonsprodukt omfattende melagatran og en faktor Xa inhibitor - Google Patents

Kombinasjonsprodukt omfattende melagatran og en faktor Xa inhibitor

Info

Publication number: NO20025909L
Authority: NO; Norway
Prior art keywords: combination product; melagatran; inhibitor; factor; pharmaceutically
Prior art date: 2000-06-10

Application number

NO20025909A

Other languages

English (en)

Norwegian (no)

Other versions

NO20025909D0 (no

Inventor

Christer Mattsson

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-10

Filing date

2002-12-09

Publication date

2003-02-07

2002-12-09 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-12-09 Publication of NO20025909D0 publication Critical patent/NO20025909D0/no

2003-02-07 Publication of NO20025909L publication Critical patent/NO20025909L/no

Links

239000013066 combination product Substances 0.000 title abstract 3
229940127555 combination product Drugs 0.000 title abstract 3
229940123583 Factor Xa inhibitor Drugs 0.000 title abstract 2
DKWNMCUOEDMMIN-PKOBYXMFSA-N melagatran Chemical compound C1=CC(C(=N)N)=CC=C1CNC(=O)[C@H]1N(C(=O)[C@H](NCC(O)=O)C2CCCCC2)CC1 DKWNMCUOEDMMIN-PKOBYXMFSA-N 0.000 title abstract 2
229960002137 melagatran Drugs 0.000 title abstract 2
239000002671 adjuvant Substances 0.000 abstract 1
239000003146 anticoagulant agent Substances 0.000 abstract 1
229940127219 anticoagulant drug Drugs 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Hematology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Liquid Crystal Substances (AREA)
Hydrogenated Pyridines (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Iron Core Of Rotating Electric Machines (AREA)

NO20025909A 2000-06-10 2002-12-09 Kombinasjonsprodukt omfattende melagatran og en faktor Xa inhibitor NO20025909L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0014136.6A GB0014136D0 (en)	2000-06-10	2000-06-10	Combination therapy
PCT/SE2001/001288 WO2001095931A1 (en)	2000-06-10	2001-06-06	A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR Xa INHIBITOR

Publications (2)

Publication Number	Publication Date
NO20025909D0 NO20025909D0 (no)	2002-12-09
NO20025909L true NO20025909L (no)	2003-02-07

Family

ID=9893354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20025909A NO20025909L (no)	2000-06-10	2002-12-09	Kombinasjonsprodukt omfattende melagatran og en faktor Xa inhibitor

Country Status (22)

Country	Link
US (1)	US20030158120A1 (es)
EP (1)	EP1294394B1 (es)
JP (1)	JP2004503508A (es)
KR (1)	KR20030007939A (es)
CN (1)	CN1431912A (es)
AT (1)	ATE322908T1 (es)
AU (2)	AU2001264494B2 (es)
BR (1)	BR0111545A (es)
CA (1)	CA2410100A1 (es)
CY (1)	CY1105068T1 (es)
DE (1)	DE60118732T2 (es)
DK (1)	DK1294394T3 (es)
ES (1)	ES2260225T3 (es)
GB (1)	GB0014136D0 (es)
HK (1)	HK1052463B (es)
IL (1)	IL152897A0 (es)
MX (1)	MXPA02011780A (es)
NO (1)	NO20025909L (es)
NZ (1)	NZ522866A (es)
PT (1)	PT1294394E (es)
WO (1)	WO2001095931A1 (es)
ZA (1)	ZA200209487B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0103590D0 (sv)	2001-10-26	2001-10-26	Astrazeneca Ab	New Combination
GB0306615D0 (en) *	2003-03-22	2003-04-30	Astrazeneca Ab	New use
WO2007008145A1 (en) *	2005-07-08	2007-01-18	Astrazeneca Ab	Heterocyclic sulfonamide derivatives as inhibitors of factor xa
AR062057A1 (es) *	2006-07-17	2008-10-15	Boehringer Ingelheim Int	Uso de los inhibidores directos de la trombina
US8790924B2 (en)	2006-10-19	2014-07-29	Duke University	Reversible platelet inhibition
SG192124A1 (en)	2011-01-25	2013-08-30	Univ Catholique Louvain	Compositions and methods for cell transplantation
US9687529B2 (en)	2011-05-05	2017-06-27	Duke University	Method of controlling coagulation
EP2806879B1 (en) *	2012-01-25	2019-03-06	Université Catholique de Louvain	Compositions and methods for cell transplantation
ES2759228T3 (es)	2013-07-05	2020-05-08	Univ Catholique Louvain	Medio acondicionado de células madre de hígado de adultos y su uso en el tratamiento de trastornos del hígado
EP2843416A1 (de) *	2013-09-02	2015-03-04	Siemens Healthcare Diagnostics Products GmbH	Kontroll- und Kalibratormaterial für die Bestimmung von direkten Antikoagulanzien
WO2016176426A1 (en)	2015-04-28	2016-11-03	Duke University	Thrombus imaging aptamers and methods of using same
EP3512526A4 (en)	2016-09-16	2020-05-27	Duke University	VON WILLEBRAND FACTOR (VWF) TARGETING AGENTS AND METHODS OF USE
US11654036B2 (en)	2020-05-26	2023-05-23	Elixir Medical Corporation	Anticoagulant compounds and methods and devices for their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9601556D0 (sv) *	1996-04-24	1996-04-24	Astra Ab	New pharmaceutical formulation of a thrombin inhibitor for parenteral use

2000
- 2000-06-10 GB GBGB0014136.6A patent/GB0014136D0/en not_active Ceased
2001
- 2001-06-06 KR KR1020027016819A patent/KR20030007939A/ko not_active Ceased
- 2001-06-06 DK DK01938923T patent/DK1294394T3/da active
- 2001-06-06 IL IL15289701A patent/IL152897A0/xx unknown
- 2001-06-06 JP JP2002510108A patent/JP2004503508A/ja active Pending
- 2001-06-06 AU AU2001264494A patent/AU2001264494B2/en not_active Ceased
- 2001-06-06 MX MXPA02011780A patent/MXPA02011780A/es active IP Right Grant
- 2001-06-06 DE DE60118732T patent/DE60118732T2/de not_active Expired - Fee Related
- 2001-06-06 ES ES01938923T patent/ES2260225T3/es not_active Expired - Lifetime
- 2001-06-06 EP EP01938923A patent/EP1294394B1/en not_active Expired - Lifetime
- 2001-06-06 US US10/297,537 patent/US20030158120A1/en not_active Abandoned
- 2001-06-06 CN CN01810227A patent/CN1431912A/zh active Pending
- 2001-06-06 CA CA002410100A patent/CA2410100A1/en not_active Abandoned
- 2001-06-06 HK HK03104744.8A patent/HK1052463B/en not_active IP Right Cessation
- 2001-06-06 AT AT01938923T patent/ATE322908T1/de not_active IP Right Cessation
- 2001-06-06 BR BR0111545-6A patent/BR0111545A/pt not_active IP Right Cessation
- 2001-06-06 PT PT01938923T patent/PT1294394E/pt unknown
- 2001-06-06 WO PCT/SE2001/001288 patent/WO2001095931A1/en not_active Ceased
- 2001-06-06 NZ NZ522866A patent/NZ522866A/en unknown
- 2001-06-06 AU AU6449401A patent/AU6449401A/xx active Pending
2002
- 2002-11-21 ZA ZA200209487A patent/ZA200209487B/en unknown
- 2002-12-09 NO NO20025909A patent/NO20025909L/no not_active Application Discontinuation
2006
- 2006-07-07 CY CY20061100937T patent/CY1105068T1/el unknown

Also Published As

Publication number	Publication date
PT1294394E (pt)	2006-07-31
ZA200209487B (en)	2004-02-23
CN1431912A (zh)	2003-07-23
HK1052463B (en)	2006-10-13
JP2004503508A (ja)	2004-02-05
IL152897A0 (en)	2003-06-24
NZ522866A (en)	2004-09-24
AU6449401A (en)	2001-12-24
HK1052463A1 (en)	2003-09-19
ES2260225T3 (es)	2006-11-01
AU2001264494B2 (en)	2006-01-05
BR0111545A (pt)	2003-07-01
CY1105068T1 (el)	2010-03-03
US20030158120A1 (en)	2003-08-21
EP1294394B1 (en)	2006-04-12
WO2001095931A1 (en)	2001-12-20
ATE322908T1 (de)	2006-04-15
EP1294394A1 (en)	2003-03-26
CA2410100A1 (en)	2001-12-20
KR20030007939A (ko)	2003-01-23
DK1294394T3 (da)	2006-07-10
GB0014136D0 (en)	2000-08-02
MXPA02011780A (es)	2003-04-10
NO20025909D0 (no)	2002-12-09
DE60118732D1 (de)	2006-05-24
DE60118732T2 (de)	2006-10-05

Legal Events

Date	Code	Title	Description
2009-02-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
MXPA03007140A (es)	2004-05-24	Derivados de carbolina.
MEP13008A (en)	2010-06-10	C-aryl glucoside sglt2 inhibitors and method
DK1294394T3 (da)	2006-07-10	Kombinationsprodukt omfattende melagatran og en faktor Xa-hæmmer
GEP20053692B (en)	2005-12-12	Substituted Alkylamine Derivatives and Methods of Use
GEP20063805B (en)	2006-04-25	Alkyne-Arylnaphthyridin-4-one as Phosphodiesterase-4 Inhibitors
NO20052787D0 (no)	2005-06-09	N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
NO20044996L (no)	2005-01-18	Furylforbindelser
MXPA02012076A (es)	2003-06-06	Compuestos quimicos.
AU2001266575A1 (en)	2002-01-08	Chemical compounds
DE60205899D1 (en)	2005-10-06	1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
DE60216233D1 (en)	2007-01-04	Carbolinderivate
MXPA03008076A (es)	2004-03-16	Isoflavonas dimericas.
AU2001263278A1 (en)	2002-01-08	Cyclic gmp-specific phosphodiesterase inhibitors
NO20025908D0 (no)	2002-12-09	Kombinasjonsprodukt omfattende melagatran og en faktor VIIa inhibitor
DK1558580T3 (da)	2008-01-14	N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner
MXPA02012472A (es)	2004-01-26	Compuestos quimicos.
MXPA04001121A (es)	2004-05-20	Derivados de fenilo.
SE0103590D0 (sv)	2001-10-26	New Combination
ATE342907T1 (de)	2006-11-15	Tumorhemmende lanthanverbindungen
DOP2002000405A (es)	2002-11-30	1-biaril-1,8-naftiridin-4-ona inhibidores de la fosfodisterasa-4.
MXPA03011724A (es)	2004-03-19	Derivados de carbohidratos.